Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000209937 | SCV004176286 | uncertain significance | Pitt-Hopkins syndrome | 2023-12-06 | reviewed by expert panel | curation | The p.His284Tyr variant in TCF4 has been reported in an individual with a neurodevelopmental phenotype (PMID 28554332). The p.His284Tyr variant is present in two XY individuals in gnomAD v4 (0.0003%) (not sufficient to meet BS1 criteria). Computational prediction analysis tools are inconclusive for this variant. In summary, the p.His284Tyr variant in TCF4 is classified as a Variant of Unknown Significance based on the ACMG/AMP criteria (no criteria met). |
Hudson |
RCV000209937 | SCV000265577 | uncertain significance | Pitt-Hopkins syndrome | 2015-10-08 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV000209937 | SCV001496511 | uncertain significance | Pitt-Hopkins syndrome | 2021-08-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001753630 | SCV001985770 | uncertain significance | not provided | 2020-07-10 | criteria provided, single submitter | clinical testing | Reported previously in an individual with severe intellectual disability, hypotonia, macrocephaly, and possible mild periventricular leukomalacia (Bowling et al., 2017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 28554332) |